A trans-translation inhibitor kills Mycobacterium tuberculosis by targeting ribosomal protein bL12
Varshney, A.; Alumasa, J. N.; Miller, A. R.; Keiler, K. C.
Show abstract
New antibiotics with novel mechanisms of action are needed to treat infections by multidrug-resistant strains of Mycobacterium tuberculosis. Here, we show that KKL-1005, an anti-tubercular triazole-based molecule, binds to ribosomal protein bL12 and specifically inhibits the trans-translation ribosome rescue pathway, a process essential for the survival of M. tuberculosis. Our data demonstrate that KKL-1005 binds to the N terminal domain of bL12, both in vitro and in bacterial cells, and specifically inhibits trans-translation and not normal translation. These results suggest that tmRNA-SmpB interacts with bL12 differently from tRNA, and raise the possibility of developing antibiotics targeting bL12.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Leaderless short ORFs in mycobacteria comprise a translational regulon 93%
- Transcriptional regulation of the Nε-fructoselysine metabolism in Escherichia coli by global and substrate-specific cues 93%
- Phosphorylation chemistry of the Bordetella PlrSR TCS and its contribution to bacterial persistence in the lower respiratory tract 93%
Similar papers in this journal
Similar papers in this journal
- Pyocin S5 import into Pseudomonas aeruginosa reveals a generic mode of bacteriocin transport 94%
- A split ALFA tag-nanobody system for protein localization and proximity proteomics in mycobacteria 94%
- Beyond self-resistance: ABCF ATPase LmrC is a signal-transducing component of an antibiotic-driven signaling cascade hastening the onset of lincomycin biosynthesis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.